Free Trial

Vanguard Group Inc. Acquires 65,478 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

Vanguard Group Inc. boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 0.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 20,183,260 shares of the medical instruments supplier's stock after purchasing an additional 65,478 shares during the quarter. Vanguard Group Inc. owned about 10.15% of DENTSPLY SIRONA worth $383,078,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in XRAY. Pacer Advisors Inc. grew its stake in shares of DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after buying an additional 4,473,972 shares during the period. Cooke & Bieler LP boosted its holdings in DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after acquiring an additional 1,794,391 shares in the last quarter. JPMorgan Chase & Co. grew its stake in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the period. American Century Companies Inc. increased its holdings in shares of DENTSPLY SIRONA by 38.2% during the fourth quarter. American Century Companies Inc. now owns 3,873,645 shares of the medical instruments supplier's stock valued at $73,522,000 after acquiring an additional 1,071,604 shares in the last quarter. Finally, National Bank of Canada FI raised its position in shares of DENTSPLY SIRONA by 85.8% during the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock worth $44,059,000 after purchasing an additional 751,800 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

XRAY has been the subject of a number of analyst reports. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their price target for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Morgan Stanley lowered their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research note on Tuesday, December 17th. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Barrington Research decreased their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $23.33.

View Our Latest Stock Report on XRAY

DENTSPLY SIRONA Stock Down 2.5 %

Shares of NASDAQ:XRAY traded down $0.34 during trading on Monday, reaching $13.24. 4,848,428 shares of the stock traded hands, compared to its average volume of 2,932,207. The stock has a market cap of $2.63 billion, a P/E ratio of -6.40, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a 50-day moving average of $17.01 and a two-hundred day moving average of $19.61. DENTSPLY SIRONA Inc. has a 52-week low of $12.54 and a 52-week high of $33.02.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.83%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.07%.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is owned by insiders.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines